249 related articles for article (PubMed ID: 29164264)
1. Risks and Benefits of Salpingectomy at the Time of Sterilization.
Castellano T; Zerden M; Marsh L; Boggess K
Obstet Gynecol Surv; 2017 Nov; 72(11):663-668. PubMed ID: 29164264
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
Venkatesh KK; Clark LH; Stamilio DM
Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
[TBL] [Abstract][Full Text] [Related]
3. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
[TBL] [Abstract][Full Text] [Related]
4. The Role of Opportunistic Bilateral Salpingectomy vs Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis.
Ely LK; Truong M
J Minim Invasive Gynecol; 2017; 24(3):371-378. PubMed ID: 28087480
[TBL] [Abstract][Full Text] [Related]
5. Postpartum Permanent Sterilization: Could Bilateral Salpingectomy Replace Bilateral Tubal Ligation?
Danis RB; Della Badia CR; Richard SD
J Minim Invasive Gynecol; 2016; 23(6):928-32. PubMed ID: 27234430
[TBL] [Abstract][Full Text] [Related]
6. [Opportunistic Salpingectomy for Permanent Contraception: A Cross Sectional Study in Portugal].
São Pedro V; Pires R; Santos F; Tovim Rodrigues C; Santos Silva I; Almeida MC; Águas F
Acta Med Port; 2021 Mar; 34(4):258-265. PubMed ID: 34214417
[TBL] [Abstract][Full Text] [Related]
7. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
[TBL] [Abstract][Full Text] [Related]
8. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
9. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
10. Female tubal sterilization: the time has come to routinely consider removal.
Creinin MD; Zite N
Obstet Gynecol; 2014 Sep; 124(3):596-599. PubMed ID: 25162262
[TBL] [Abstract][Full Text] [Related]
11. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
Hanley GE; McAlpine JN; Pearce CL; Miller D
Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
[TBL] [Abstract][Full Text] [Related]
12. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
[TBL] [Abstract][Full Text] [Related]
13. Benefits and Risks of Bilateral Salpingectomy Compared With Standard Tubal Ligation During Cesarean Delivery for Permanent Postpartum Contraception.
Luke S; Addae-Konadu K; Davidson B; Kuller J; Dotters-Katz S
Obstet Gynecol Surv; 2022 Mar; 77(3):167-173. PubMed ID: 35275215
[TBL] [Abstract][Full Text] [Related]
14. Complete salpingectomy versus tubal ligation during cesarean section: a systematic review and meta-analysis.
Yang M; Du Y; Hu Y
J Matern Fetal Neonatal Med; 2021 Nov; 34(22):3794-3802. PubMed ID: 31752570
[TBL] [Abstract][Full Text] [Related]
15. Ovarian reserve following cesarean section with salpingectomy vs tubal ligation: a randomized trial.
Ganer Herman H; Gluck O; Keidar R; Kerner R; Kovo M; Levran D; Bar J; Sagiv R
Am J Obstet Gynecol; 2017 Oct; 217(4):472.e1-472.e6. PubMed ID: 28455082
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
[TBL] [Abstract][Full Text] [Related]
17. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.
McAlpine JN; Hanley GE; Woo MM; Tone AA; Rozenberg N; Swenerton KD; Gilks CB; Finlayson SJ; Huntsman DG; Miller DM;
Am J Obstet Gynecol; 2014 May; 210(5):471.e1-11. PubMed ID: 24412119
[TBL] [Abstract][Full Text] [Related]
18. Safety outcomes of female sterilization by salpingectomy and tubal occlusion.
Westberg J; Scott F; Creinin MD
Contraception; 2017 May; 95(5):505-508. PubMed ID: 28232128
[TBL] [Abstract][Full Text] [Related]
19. Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
Mandelbaum RS; Matsuzaki S; Sangara RN; Klar M; Matsushima K; Roman LD; Paulson RJ; Wright JD; Matsuo K
Am J Obstet Gynecol; 2021 Oct; 225(4):399.e1-399.e32. PubMed ID: 34181896
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
